Group items tagged

Surgical robots are designed to do much more than simple surgeries, including complex surgeries that are usually only done under very complicated circumstances. For example, a surgical robot that is used to help urologists insert hyaluronic acid pellets into the penis is able to perform this surgery without placing the patient at risk for any kind of infection. Growing demand awareness regarding the advantages of robotic-assisted surgery coupled with the advancement in the surgery is fueling the market growth of surgical robots. Increasing adoption of surgical robots across hospitals & ambulatory surgery centers in order to reduce human error and improve patient safety is again driving the market growth of surgical robots. According to the International Federation of Robotics, the total value of sales of medical robots increased to US$1.9 billion, accounting for 29 percent of the total sales value of the professional service robots in 2017. Moreover, expanding application of surgical robots across various surgeries such as general surgery, gynecological surgery, urological surgery, neurosurgery, orthopedic surgery, and other applications is also expected to uplift the market growth. Growing focus on improving surgeries with better precision and outcome is further anticipated to bolster the market growth of surgical robots. A rise in the funding in the field of surgical robots for developing more advanced cost-effective robots is anticipated to foster the market growth of the surgical robots. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/surgical-robots-addresses-complex.html

The global dialysis market is expected to grow at a steady rate, indicating a CAGR of 5.0% during the forecast period 2019-2025. This is one of the most serviced market in the healthcare industry. The factors that drive the growth of this market include increasing incidence of ESRD diseases, along with a rise in chronic diseases such as diabetes and hypertension. The surge in funding by government and private sectors for dialysis has helped the market witness steady growth. In addition, the increased disposable income also acts as a growth driver. However, the high embedded costs and related challenges in the dialysis industry, along with lack of kidney donors and reduction in reimbursement is expected to dampen the growth of this market.

The global market for chronic kidney disease drugs is expected to witness single-digit growth during 2019-2025. The drug pipeline of chronic kidney disease looks promising with novel therapeutic approaches, such as cell therapy, likely to enhance the market growth opportunities. However, the competition from biosimilars and complex drug development processes are impeding the market growth. Over the period, extensive research is being done to fill the unmet needs' gap. The advances in the arena of regenerative treatment have come up with budding advancement of cell therapies that help regeneration and repairing of the kidneys. Cell therapy is proficient of refining the fundamental functioning capability of the kidney. Uncontrolled high blood pressure and diabetes are the leading causes of kidney failure globally.

Growth of the surgical drains market is majorly driven by rise in chronic diseases and increase in the number of surgeries has also resulted in the growth of the market due to the increasing usage of these devices in various applications. Furthermore, increase in geriatric population and technological advancements made in the field of surgical drains and focus of manufacturers on developing advanced and innovative tubes are the key factors driving the growth of surgical drains market. For instance, in May 2020, SOMAVAC Medical Solutions, Inc. announced the launch of the SOMAVAC SVS and a partnership with A Fitting Place.

The major factor affecting the marketgrowth includes the advancement in the GLP-1 receptor agonist such that it could meet the market demand amalgamated with the stronger product pipeline. This would help the market to gain traction during the forecast period. There has been an increase in the number of diabetic patients and other disorders such as obesity that may cause diabetes, which would propel the growth of the market in the coming years. However, the product failure may hinder the growth of the market.

Varicose veins are abnormal, dilated blood vessels caused by weakening of the vessels walls. These veins appeared to be swollen, twisted, cluster of blue or purple veins under the skin. Varicose vein disorder affects millions of people all around the world Symptoms usually appear at age of 40 and generally appeared in the legs. Varicose vein is harmful to health if they lead to venous stasis ulcers, phlebitis, thrombosis, venous hemorrhage, or fungal and bacterial infections. According to the American Society of Vascular surgery, at least 20 to 25 million Americans are suffering from varicose vein, among them 17% are men and 33% are women. The varicose vein treatment analysis is done on the basis of the exhaustive primary and secondary regional wise to understand the factors responsible for growth and factors hampering the growth of the market.

Companion diagnostics is a clinically established diagnostic tool used in conjunction with a therapeutic agent to identify the applicability of that drug to an individual patient. Companion diagnosis is generally the last step of drug management and usually involves a process of screening, evaluating, and prescribing medication based on the findings of companion diagnostics. A companion diagnose determines whether a particular drug therapy is suitable for the patient in terms of safety, toleration, and response to treatment. It is basically an advanced form of drug management that focuses on evaluating and implementing personalized treatment plans based on known medical issues and considerations. Increasing prevalence of cancer is expected to propel growth of the global companion diagnostics market over the forecast period. For instance, according to the American Cancer Society, in 2020, around 276,480 new cases of invasive breast cancer will be diagnosed in women and the disease will lead to around 42,170 deaths, in the U.S. Moreover, increasing development and commercialization of new products is also expected to aid in growth of the market. For instance, in November 2020, LabCorp announced an expanded agreement with BML, a leading Japanese provider of clinical laboratory testing services, to provide development and delivery of companion diagnostics in Japan. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/increasing-prevalence-of-cancer-and.html

Developing your healthcare IT company into an industry leader may not be an easy feat, but it is surely achievable if you use competent growth strategies. Check if these growth strategies work for you.

Rise in prevalence of disorders cases such as kidney stones, urinary incontinence, and kidney transplants drives the market growth.

Catheter ablation would propel the market growth with a very high rate, as these devices are used for the treatment of atrial fibrillation when medications are not effective. Catheter ablation procedure is very low risk and minimally-invasive in nature than other surgery (such as MAZE surgery).

Global Internet of Medical Things market (IoMT) is predicted to grow at a significantly high growth rate during the forecast period (2018-2023). In the medical device industry, major growth has been observed as IoT based medical technology has been adopted widely in developed economies. The IoMT is a collection of medical devices and applications connected to healthcare IT systems via online computer networks.

Upsurge in cases with chronic disorders and increase in failed cases of medical implants due to bacterial infections make it imperative to integrate antibacterial coatings in medical implants. Moreover, advancement & inclination toward biocompatible coatings, rise in orthopedic, dental and cardiac disorders, and growth in affordability in developing economies are projected to supplement the market growth.

The market for varicose vein treatment is highly fragmented; the increasing prevalence of varicose veins and growing geriatric population are among the primary factors driving the market growth. However, the high cost of treatment procedure and lack of skilled professionals are hampering the growth of the market. The treatment cost for varicose veins is high and the reimbursement scenario is very inconsistent. In 2018, 3 out of 10 individuals were affected by varicose veins with health expenses being more than $10 billion. These costs have increased annually due to a sedentary lifestyle, growing elderly population, and the prevalence of obesity.

Global drug discovery services market will continue to grow, owing to upsurge in externalization of R&D activities, rising expenditure on R&D, and increasing incidence of chronic diseases. Expiration of patents boosting the demand for drug discovery and the introduction of innovative drug discovery technologies are projected to support the market growth during the forecast period 2019-2025. The global drug discovery services market, by type, is segmented into medicinal chemistry services, biology services, and pharmacokinetics and drug metabolism. Among these, the medicinal chemistry services segment accounted for the largest share in 2018 and is expected to grow at a high-double-digit CAGR by 2025. Increasing tendency of pharma companies to externalize discovery & development services, upsurge in the number of drug discovery & development activities, and growing R&D expenditure are the key factors driving the growth of the segment.

Machined parts are the most widely used components in almost every industry. Nuts, bolts, screws, inserts, fasteners, couplings, pins shafts, are an integral part of the medical industry. They are used in all aspects of the field to deliver optimum performance. Fasteners of various types, specifications, and capacities are used depending on application requirements. Fasteners are used in a range of diagnostic products and medical devices, such as medical instruments, medical equipment, and medical implants. The dental implant is a surgical component that supports a dental prosthesis, such as a bridge, crown, facial prosthesis, denture, or acts as an orthodontic anchor. The dental implant acts as a replacement for the root of a missing tooth. It an option for people who have lost a tooth or teeth due to periodontal disease, an injury, or some other reason. According to the FDI World Dental Federation, oral disorders affect more than 3.9 million people worldwide. Acceptance level for dental implants is increasing due to limitations of removable prosthetics, such as lack of natural appearance, discomfort, and need for maintenance. Prosthetics play an important role in boosting the demand for these implants through oral rehabilitation, which helps restore a patient's oral function and facial contours. Moreover, prosthetics placed on the dental implants do not intrude soft tissues and enhance aesthetics, which is expected to propel the market growth. Moreover, dental implants improve a person's physical appearance and provide comfort and convenience. A prosthesis is an artificial device that replaces a missing body part that might be lost through trauma, congenital factors, or various other diseases. Prostheses are designed to restore the normal functions of the missing body part. Prosthetics enhance the function and lifestyle of persons with limb loss through the usage of artificial limbs. Lower limb prostheses can address stability in cosmetic appearance, shock absor

The major factor affecting the industry includes surge in product developments such that it meets the requirement posed by the market, which would help the industry in the coming years.Majority of key players are investing in product innovations and launching newer products that are cost efficient and hence are expected to help the industry gain traction during the forecast period. Furthermore, companies are focusing in mergers and acquisitions so that they are able to increase distribution channels across various regions, which is anticipated to boost the market growth.

The major factor affecting the industry includes increase technological advancements in the fill-finish manufacturing processes, which are designed such that it meets the market demand. There is a steep growth observed in the biopharmaceutical industry, which would help the industry gain traction in the coming years.Furthermore, surge in adoption of prefilled syringes for parenteral dosage forms would help the industry boost in the next few years.